Aureate Tradde Limited IPO DHRP Analysis
Updated: Aug 11
SME IPO Analysis BSE SME Platform
Based on Prospectus dated May 23, 2026 | Fixed Price Issue
STATUS: PROSPECTUS FILED | Issue Open: May 29, 2026 | Issue Close: June 2, 2026 | Issue Price: ₹70 | 100% Fresh Issue | BSE SME Listing
Aureate Tradde Limited (ATL) is a Mumbai based trading and distribution company operating in three industrial segments: Polymers and Petrochemicals, Lithium ion and Sodium ion Cells, and Electric Vehicle Chargers. Originally incorporated in August 2018 as MM9 Polytrade Private Limited, the company went through two name changes before converting to a public limited company in April 2025. Its promoters, Mrs. Kalash Kevin Shah and Mr. Punit Devendrabhai Shah, represent the third generation of a family that has been in the plastics and petrochemicals trade since 1981.
ATL operates on an inventory based model. It imports materials from international manufacturers, stores them at rented warehouses in Delhi, Gujarat (Kachchh), and Maharashtra (Bhiwandi), and distributes them to B2B customers across India. The company does not own its warehouse infrastructure. Physical stock control is managed by warehouse operators, with ATL maintaining reconciliation records.
The three business verticals are:
Polymers and Petrochemicals is the oldest and largest revenue contributor. ATL trades PVC Resins (multiple grades for pipes, profiles, cables), PET Resins for bottles, and Polyethylene grades including LDPE and HDPE. Customers include plastic product manufacturers and packaging companies. The company sources from established international vendors including LyondellBasell.
Lithium ion and Sodium ion Cells is a newer and strategically important segment. ATL is the exclusive pan India distributor of Sodium ion Cells for Jianghu Highstar Battery Manufacturing Co. Ltd., a Chinese manufacturer specialised in secondary chemical power products. Sodium ion cells are emerging as the preferred battery technology for two and three wheeler EVs due to faster charging, better safety, and lower cost compared to lithium ion alternatives.
Electric Vehicle Chargers covers both B2B and B2C trading and distribution of lithium and lead acid chargers, and EV charging infrastructure equipment. This segment addresses India's rapidly growing EV adoption and the parallel demand for charging networks.
The company is ISO 9001:2015 certified and holds no manufacturing assets. All products are sourced and resold; ATL has no production capability. Revenue is entirely from trading margins.
Key Basics
This is a Fixed Price SME IPO not a book built main board issue. The issue price of ₹70 per share has been pre determined by the company in consultation with the Lead Manager. There is no book building, no anchor investor allocation, and no QIB or NII category. It is a 100% Fresh Issue with no Offer for Sale.
Detail | Information |
Issue Type | Fixed Price 100% Fresh Issue. No OFS. No book building. |
Total Issue Size | Up to 38,98,000 equity shares at ₹70 each aggregating ₹27.29 crore (₹2,728.60 lakh) |
Market Maker Reservation | 1,96,000 shares (₹1.37 crore) compulsory for SME listings to provide liquidity post listing |
Net Issue to Public | 37,02,000 shares (₹25.91 crore) split 50:50 between individual investors (min application size) and other investors |
Face Value and Issue Price | Face Value ₹10 per share | Issue Price ₹70 per share (7x face value) |
Pre IPO Share Capital | 90,87,736 equity shares |
Post IPO Share Capital | 1,29,85,736 equity shares. Public holds 30.02% post issue. |
Promoter Holding (Pre IPO) | Mrs. Kalash Kevin Shah and Mr. Punit Devendrabhai Shah. No OFS promoters not selling any shares. |
Promoter Acquisition Cost | Weighted average cost of acquisition of promoter shares is ₹4.45 per share. Issue price of ₹70 implies a 15.7x premium over promoter entry cost. |
Listing Exchange | BSE SME Platform (not main board BSE or NSE) |
Lead Manager | Corporate Makers Capital Limited, New Delhi |
Registrar | MUFG Intime India Private Limited (formerly Link Intime India Private Limited) |
Issue Open and Close | Opens: Friday, May 29, 2026 | Closes: Tuesday, June 2, 2026 |
SME IPO note: BSE SME listings have significantly lower liquidity than main board stocks. A market maker is mandatorily appointed to provide two way quotes post listing, but trading volumes are typically thin. Investors should factor in exit liquidity risk before applying.
How Will the IPO Money Be Used?
Gross proceeds: ₹27.29 crore. After deducting issue expenses of ₹3.27 crore (11.99% of gross proceeds, which is high), net proceeds available to the company are ₹24.01 crore (₹2,401.40 lakh). None of the objects have been appraised by any bank or financial institution.
Object | Amount (₹ lakh) | Details |
Funding Working Capital Requirements | 1,000.00 | To fund trade receivables and inventory build up as business scales. Total working capital gap was ₹44.83 crore as of December 31, 2025. |
Repayment of Borrowings | 992.75 | Axis Bank LAP 1: ₹169.43 lakh | Axis Bank LAP 2: ₹169.43 lakh | Union Bank Cash Credit: ₹653.89 lakh |
General Corporate Purposes | 408.65 | Capped at 15% of gross proceeds or ₹10 crore, whichever is lower. At management discretion. |
Key observations: Working capital is the single largest use (41.7% of net proceeds), reflecting ATL's capital intensive trading model with long receivable and inventory cycles. Debt repayment of ₹9.93 crore will partially reduce the outstanding indebtedness of ₹38.07 crore as of December 31, 2025 a meaningful but incomplete reduction. Issue expenses of ₹3.27 crore (11.99% of gross proceeds) are on the higher side and represent a real cost to incoming shareholders. The full deployment is planned in FY 2026-27.
Financial Performance
Note: All figures are in ₹ lakh unless stated otherwise. ₹1 crore = ₹100 lakh. The 9 month period covers April 1 to December 31, 2025.
Revenue from Operations
Revenue has declined over the three completed fiscal years, recovering in the partial year. ATL reported revenue of ₹209 crore in FY2023, which fell to ₹170.75 crore in FY2024 and recovered marginally to ₹174.41 crore in FY2025. For the 9 months ended December 2025, revenue was ₹101.83 crore, implying an annualised run rate of approximately ₹135.77 crore, still below FY2025 full year levels. The three year revenue CAGR is negative at (8.65)%. Management attributes this to a reduction in unit selling prices rather than volume decline, and notes that volumes have actually increased. The expansion into lithium ion cells, sodium ion cells, and EV chargers is expected to drive future revenue growth.
Profitability
Metric | FY2023 (₹L) | FY2024 (₹L) | FY2025 (₹L) | 9M FY2026 (₹L) |
Revenue from Operations | 20,900.48 | 17,074.81 | 17,440.60 | 10,183.01 |
EBITDA | 7.75 | 324.52 | 506.89 | 732.95 |
EBITDA Margin | 0.04% | 1.90% | 2.91% | 7.20% |
PAT | 112.86 | 144.72 | 257.42 | 435.77 |
PAT Margin | 0.54% | 0.85% | 1.48% | 4.28% |
Finance Costs | 129.62 | 280.18 | 361.13 | 212.53 |
EPS (Basic and Diluted, ₹) | 1.25 | 1.60 | 2.83 | 4.80 |
The standout story is margin expansion. EBITDA margin was essentially zero (0.04%) in FY2023 and has expanded to 7.20% in the 9 months ended December 2025. PAT has nearly quadrupled from FY2023 to the 9M FY2026 run rate. At an annualised PAT of approximately ₹5.81 crore (extrapolating 9M FY2026), the P/E at the issue price of ₹70 is approximately 15.6x on an annualised basis significantly more attractive than the headline 24.73x P/E cited in the prospectus which uses FY2025 EPS of ₹2.83. Finance costs have also declined in 9M FY2026 relative to FY2025, suggesting some deleveraging benefit is already visible.
Return Ratios
ROCE has improved from a negative (0.91%) in FY2023 to 25.07% by December 2025. RONW has improved from 18.41% (FY2024) to 28.87% (9M FY2026). These are strong return metrics for a trading company. Net Worth has grown from ₹5.14 crore (FY2023) to ₹17.24 crore (December 2025), reflecting retained profits and the share capital issued during the period.
Cash Flow The Persistent Concern
Operating cash flow has been negative in every single period reported. FY2023: negative ₹1.12 crore. FY2024: negative ₹2.59 crore. FY2025: negative ₹0.27 crore. 9M FY2026: negative ₹2.90 crore. The core reason is the working capital model of ATL: trade receivables and inventories expand faster than trade payables, consuming cash.
Trade receivable days went from 14 days (FY2023) to 109 days (December 2025). Inventory days went from 31 (FY2023) to 105 (December 2025). The company is profitable but cash poor a common and dangerous dynamic in trading businesses that grow quickly. The IPO proceeds targeting working capital and debt repayment are directly addressing this structural issue.
Balance Sheet Snapshot (December 31, 2025)
Total assets: ₹98.58 crore. Total equity (net worth): ₹17.24 crore. Total borrowings: ₹38.07 crore. The balance sheet is heavily skewed towards current assets, with inventory at ₹36.37 crore and trade receivables at ₹41.18 crore together accounting for 78.5% of total assets. Cash and cash equivalents are a very thin ₹0.43 crore.
Short term borrowings (₹24.97 crore) and long term borrowings (₹13.10 crore) together represent a debt to equity ratio of approximately 2.21x, which is elevated for a trading company and is partly why the IPO proceeds are being used for debt repayment.
Revenue Composition and Geopolitical Impact
Polymers and petrochemicals remain the dominant revenue driver, though the prospectus does not provide a formal segment wise revenue split. What is disclosed is that the company's total working capital requirement grew from ₹21.68 crore (FY2023) to ₹44.83 crore (December 2025) more than doubling in two years.
A critical disclosure buried in the working capital section: The company has a pending order book of ₹70.78 crore and purchase orders of ₹44.45 crore, totalling ₹1,15.23 crore for FY 2025-26. Of this, ₹48.47 crore of orders were completed by March 31, 2026, leaving ₹66.76 crore of orders pending due to disruptions from ongoing geopolitical situation.
This geopolitical reference (likely the India-Pakistan tensions of May 2026 or broader global supply chain issues) has directly inflated both trade receivables (109 days vs normalised 60 days) and inventories (105 days vs normalised 60 days). The company expects both to normalise to 60 day cycles in FY2026-27 projections, which is an optimistic assumption that investors should scrutinise.
How Does It Compare to Peers?
The prospectus identifies only one listed peer: Bhavik Enterprises Limited. The company acknowledges there is no truly comparable listed company and uses Bhavik Enterprises as the closest approximation since majority revenue comes from polymers and petrochemicals. This is an important caveat Bhavik is a much larger business at ₹527 crore in FY2025 revenue versus ATL's ₹174 crore. The EV cells and charger business has no listed comparable at all.
Company | Revenue FY25 (₹L) | EPS FY25 (₹) | P/E (May 2026) | RONW % | EBITDA Margin |
Aureate Tradde Limited | 17,440.60 | 2.83 | 24.73x (issue price) | 21.88% | 2.91% |
Bhavik Enterprises Limited | 52,726.71 | 3.58 | 43.85x (CMP ₹157) | 5.97% | 0.70% |
On RONW (21.88% vs 5.97%) and EBITDA margin (2.91% vs 0.70%), ATL actually compares favourably to its listed peer. ATL's issue P/E of 24.73x based on FY2025 EPS is also lower than Bhavik's 43.85x P/E, which provides some valuation comfort.
However, Bhavik's revenue is 3x larger, which gives it procurement scale and customer diversification advantages that ATL does not have. Given the 9M FY2026 EPS of ₹4.80 (annualised approximately ₹6.40), the forward P/E at issue price of ₹70 is approximately 10.9x which is attractive relative to Bhavik's 43.85x if the earnings momentum is sustained.
Key Risks
• Section 185 Compounding Application a serious compliance red flag: The company has filed a compounding application with the Registrar of Companies (ROC) Mumbai on December 2, 2025, for non-compliance with Section 185 of the Companies Act 2013. Section 185 prohibits loans to directors and related parties.
This means ATL made loans to related parties in violation of company law. The related party transactions table shows significant loans extended to MIX MEDIA SIGNAGES LLP (₹1,500.47 lakh given during the period, ₹1,000.53 lakh repaid), which is an entity where KMP have significant influence. The penalty amount cannot yet be ascertained. This is a governance concern that typically would be resolved before an IPO.
• Revenue has declined over three years (FY2023 to FY2025): Revenue fell from ₹209 crore (FY2023) to ₹174 crore (FY2025), a decline of 16.7% over two years. The three year revenue CAGR is negative at (8.65)%. While management explains this as price deflation rather than volume loss, a trading company that is generating lower revenues year on year despite growing its working capital requirement is a structural concern. The 9M FY2026 recovery is encouraging but not yet a confirmed trend.
• Operating cash flow has been negative in every single period: FY2023, FY2024, FY2025, and 9M FY2026 all show negative operating cash flows. The business generates accounting profits but cannot convert them to cash because working capital is growing faster than revenue. Trade receivable days have expanded from 14 to 109 and inventory days from 31 to 105 in just three years. A company that cannot generate operating cash while growing is inherently dependent on external financing including this IPO.
• Total borrowings of ₹38.07 crore against net worth of ₹17.24 crore: Debt to equity stands at approximately 2.21x as of December 2025. For a small trading company with no manufacturing assets, this is a meaningful leverage. Finance costs of ₹2.13 crore consumed approximately 48.9% of PAT in 9M FY2026. The IPO will repay ₹9.93 crore of this debt, improving the ratio to approximately 1.63x post listing, which is better but still high.
• Delhi warehouse lease expires June 30, 2026 just after the IPO closes: The prospectus discloses that the Delhi warehouse lease (from which polymers and EV chargers are distributed) has been extended only until June 30, 2026. The IPO closes June 2, 2026. If the lessor does not renew, the company loses its Delhi distribution point immediately post IPO. This is an operational continuity risk disclosed in the risk factors.
• Promoter weighted average acquisition cost is ₹4.45 IPO is at ₹70: Promoters acquired their shares at an effective cost of ₹4.45 per share (largely through bonus issues). At the issue price of ₹70, they are listing at 15.73x their entry cost. While promoters are not selling shares in the IPO, this extreme dilution of book cost versus issue price indicates that incoming investors are paying a significant premium to early equity holders, who received shares at token prices.
• No manufacturing asset 100% dependent on suppliers and warehouse operators: If key suppliers withdraw, raise prices, or face disruptions, ATL has no fallback manufacturing capability. The exclusive sodium ion cell distributorship from Jianghu Highstar could be terminated. All warehouses are rented with fixed lease terms.
• Single listed peer valuation difficult to verify: There is no truly comparable listed company for a business spanning polymer trading, lithium ion cells, sodium ion cells, and EV chargers. The comparison with Bhavik Enterprises is approximate at best.
• Heavy import dependence with geopolitical exposure: The delayed order book of ₹66.76 crore is attributed to geopolitical disruptions. ATL imports from China (sodium ion and lithium ion cells) and other international markets. Any escalation in trade tensions, import duties, or currency movements directly affects procurement costs and supply availability.
• No monitoring agency appointed: As this issue is below ₹50 crore, no monitoring agency is required. Fund deployment will be monitored only by the company's own audit committee. There is no independent third party oversight of IPO proceed utilisation.
• Related party loans and complex intergroup transactions: The related party transaction table shows significant loans given to and received from promoters, their relatives, and affiliated entities across all periods. Mix Media Signages LLP (a promoter affiliated entity) received ₹15.00 crore in loans during 9M FY2026 alone. These transactions, combined with the Section 185 compounding application, indicate that the boundary between company funds and promoter related entities has not been clearly maintained.
• Geopolitical disruption has inflated receivable and inventory days: The company projects receivable days and inventory days to normalise to 60 each in FY2026-27 from 109 and 105 currently. If this normalisation does not happen as projected, working capital requirements will remain high and the ₹10 crore working capital infusion from the IPO may prove inadequate.
Positives
• PAT growing strongly despite revenue decline: PAT has grown every year: ₹1.13 crore (FY2023) to ₹1.45 crore (FY2024) to ₹2.57 crore (FY2025) to ₹4.36 crore in just 9 months of FY2026. This consistent profit growth, even as revenue fell, reflects improving trading margins and operational discipline.
• EBITDA margin expanded dramatically from 0.04% to 7.20% in 3 years: This margin expansion from near zero to 7.20% in three years is the most compelling financial story in this prospectus. It suggests the product mix is shifting towards higher margin items (sodium ion cells, EV chargers) and that procurement and pricing discipline is improving.
• Strong return ratios RONW of 28.87% and ROCE of 25.07%: These are high quality return metrics for a small trading company and compare favourably to the listed peer Bhavik Enterprises (RONW 5.97%, ROCE 3.68%). The capital is being used efficiently.
• Exclusive pan India distributor of Sodium ion Cells for Jianghu Highstar: This sole distributorship for an emerging battery technology gives ATL a defensible niche. Sodium ion cells are gaining traction in the two and three wheeler EV market in India, and being the only authorised distributor creates a temporary monopoly advantage.
• 100% Fresh Issue company gets all proceeds: Unlike many SME IPOs that involve promoter exit, this is entirely a growth capital raise. The promoters are not selling a single share. All ₹24 crore of net proceeds go to the company for working capital and debt reduction.
• Low forward P/E of approximately 10.9x on annualised 9M FY2026 earnings: At an annualised PAT run rate of approximately ₹5.81 crore and issue price of ₹70, the forward P/E is approximately 10.9x. This is materially lower than the peer P/E of 43.85x and represents an attractive entry multiple if earnings momentum continues.
• Third generation promoter family with 28 years combined experience: The promoters come from a family with four decades of history in the polymer trade. This domain expertise and supplier relationship network is a real competitive advantage in a business where terms, credit periods, and product availability are relationship driven.
Aureate Tradde Limited is a profitable, improving business with a credible niche in an emerging segment (sodium ion cells) and strong return ratios. The margin expansion story from 0.04% to 7.20% EBITDA is genuinely impressive. However, this is a small, import dependent trading company with a pending corporate law violation, consistently negative operating cash flows, elevated leverage, and a revenue base that has actually shrunk over three years.
The Section 185 compounding application is a governance concern that demands careful attention. On valuation, the forward P/E of approximately 10.9x looks attractive against the peer at 43.85x but SME IPO valuations rarely reflect fundamental value alone. The thin post listing liquidity on the BSE SME platform is also a practical exit risk.
This is best suited for investors comfortable with small company risk, who can hold through potential near term volatility, and who believe the sodium ion cell distributorship and EV charger business can scale significantly in the next two to three years.
Disclaimer
The content on this website is for informational and educational purposes only and should not be construed as investment advice, a recommendation, or a solicitation to buy or sell any security, mutual fund, or financial instrument. Equity Research India is not a SEBI-registered investment advisor or research analyst, and nothing on this site constitutes personalized financial advice.
Mutual fund investments are subject to market risks. Please read all scheme-related documents carefully before investing. Past performance is not indicative of future returns. NAV, returns, rankings, and other data may change and may not reflect the most current information at the time of reading.
Readers should conduct their own due diligence and consult a SEBI-registered financial advisor before making any investment decisions. Equity Research India and its authors accept no liability for any loss or damage arising from the use of this content.



Comments